Skip to main content

Table 3 IC50 average parameters in nM for wild type (K76) and mutant (76T) P. falciparum isolates from West Africa and Central Africa for piperaquine (PPQ), quinine (QN), mefloquine (MQ), chloroquine (CQ), lumefantrine (LMF), desethylamodiaquine (DQ), pyronaridine (PND), dihydroartemisinin (DHA) and artesunate (AS)

From: Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates

Drugs

West Africa

Central Africa

Wild type K76 (n = 76)

Mutant 76T (n = 27)

p value

Wild type K76 (n = 82)

Mutant 76T (n = 14)

p value

Median

Min–Max

Median

Min–Max

Median

Min–Max

Median

Min–Max

CQ

23.2

5.5–229.6

152.6

7.9–381

4.295E−10

28.7

5.1–474.4

113.1

14.2–325

0.0002

DQ

19.3

2.5–185.1

46.2

6.5–169.2

0.0002

20.1

4.7–85.8

32.9

16.3–152.9

0.002

QN

138.6

6.2–906.3

163.8

36.7–586

0.2

143.9

28.9–538.4

180.1

17.6–503

0.52

LMF

3.9

0.5–31.6

3.5

0.5–61.5

0.3

3.1

0.5–27.3

4.9

0.6–14.2

0.758

MQ

25.2

0.8–89.8

26.2

2.9–76.7

0.8

23.7

1.04–86.6

40.9

0.7–92.3

0.11

DHA

2.9

0.2–12.8

2.8

0.5–8.2

0.9

2.9

0.5–18.5

2.9

0.7–6.5

0.78

PND

11.8

1.1–119.3

13.3

1.9–50.2

0.7

11.3

0.2–46.6

12.3

2.7–40.8

0.99

AS

1.8

0.3–64

2.1

0.4–7.3

0.8

1.9

0.3–30.2

3.0

0.6–5.9

0.36

PPQ

20.2

1.2–78.9

28.6

7.4–544

0.08

20.6

0.7–84.6

20.9

3.4–67.1

0.82

  1. West Africa: Benin, Burkina Faso, Gambia, Ghana, Guinea, Ivory Coast, Niger, Mali, Nigeria and Togo
  2. Central Africa: Cameroon, Central African Republic, Chad, Gabon and Republic of Congo
  3. Italic p values refers to significant difference (p < 0.05)